Klev Gaïtan Sikam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Klev Gaïtan Sikam has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Gervais Mouthé Happi
Higher Technical Teachers Training College, University of Douala, Douala P.O. Box 2701, Cameroon
9 shared publications - Jean Duplex Wansi
Department of Chemistry, Faculty of Sciences, University of Douala, P.O. Box 24157, Douala, Cameroon
8 shared publications - Liliane Clotilde Dzouemo
Department of Chemistry, Faculty of Sciences, University of Douala, P.O. Box 24157, Douala, Cameroon
5 shared publications Jacqueline Poffelie Kamegne
Department of Organic Chemistry, University of Yaounde I
2 shared publicationsJean Duplex Wansi
2 shared publications- Livine Zemo Meikeu
Department of Chemistry, Higher Teacher Training College, The University of Bamenda, P.O Box 39 Bambili, Cameroon
2 shared publications
Latest Publications
- 11 February 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-8
Triterpenoids and steroids from the stem bark of Caloncoba glauca (P. Beauv.) Gilg (Achariaceae)
Two previously unreported triterpenoids, glaucalic acid (1) and glaucalactone D (2), together with five known compounds identified as trichadenic acid B (3), friedelin (4), β-sitosterol (5), stigmasterol (6), and stigmasterol 3-O-β-D-glucopyranoside (7), were isolated from the methanolic extract of the stem bark of Caloncoba glauca (Achariaceae). The structural elucidation of all isolated compounds was achieved through the analysis of spectroscopic data, which included one-dimensional and two-dimensional nuclear magnetic resonance (NMR) spectroscopy, high-resolution mass spectrometry (HRMS), and comparisons with published data. These findings expand the known chemical diversity of the genus Caloncoba and reinforce the significance of friedelane-type triterpenoids as chemomarkers for this genus.
- 11 February 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-8
Triterpenoids and steroids from the stem bark of Caloncoba glauca (P. Beauv.) Gilg (Achariaceae)
Two previously unreported triterpenoids, glaucalic acid (1) and glaucalactone D (2), together with five known compounds identified as trichadenic acid B (3), friedelin (4), β-sitosterol (5), stigmasterol (6), and stigmasterol 3-O-β-D-glucopyranoside (7), were isolated from the methanolic extract of the stem bark of Caloncoba glauca (Achariaceae). The structural elucidation of all isolated compounds was achieved through the analysis of spectroscopic data, which included one-dimensional and two-dimensional nuclear magnetic resonance (NMR) spectroscopy, high-resolution mass spectrometry (HRMS), and comparisons with published data. These findings expand the known chemical diversity of the genus Caloncoba and reinforce the significance of friedelane-type triterpenoids as chemomarkers for this genus.
- 13 March 2025
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 24 (6) , 5995-6043
Vernonia sesquiterpene lactones: a review of their chemical and pharmacological aspects
- 13 March 2025
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 24 (6) , 5995-6043
Vernonia sesquiterpene lactones: a review of their chemical and pharmacological aspects
- 25 September 2024
- Published by Taylor & Francis in Natural Product Research
- Vol. 39 (24) , 7126-7134
Antiplasmodial specialised compounds from the leaves of Guarea glomerulata Harms (Meliaceae)
To the best of our knowledge, this is the first chemical study of Guarea glomerulata that led to the isolation and characterisation of nine distinct compounds from its methanolic leaves extract including one new trinortriterpenoid glomerulatin along with eight known compounds amongst which five compounds namely azadirone, oleanolic acid, sericoside, cleomiscosin D and griffonin reported for the first time from the genus Guarea. All the isolated compounds have been evaluated in vitro for their antiplasmodial potency against the chloroquine-sensitive strain P. falciparum 3D7. The results showed that glomerulatin and azadirone were the most active compounds with IC50 values of 1.02 ± 0.2 μM and 1.48 ± 0.4 μM, respectively. This study enriches the chemistry of the genus Guarea and further supports the identification of Meliaceae plants as a good source of antiplasmodial candidates for the development of new potent drugs against malaria.
- 25 September 2024
- Published by Taylor & Francis in Natural Product Research
- Vol. 39 (24) , 7126-7134
Antiplasmodial specialised compounds from the leaves of Guarea glomerulata Harms (Meliaceae)
To the best of our knowledge, this is the first chemical study of Guarea glomerulata that led to the isolation and characterisation of nine distinct compounds from its methanolic leaves extract including one new trinortriterpenoid glomerulatin along with eight known compounds amongst which five compounds namely azadirone, oleanolic acid, sericoside, cleomiscosin D and griffonin reported for the first time from the genus Guarea. All the isolated compounds have been evaluated in vitro for their antiplasmodial potency against the chloroquine-sensitive strain P. falciparum 3D7. The results showed that glomerulatin and azadirone were the most active compounds with IC50 values of 1.02 ± 0.2 μM and 1.48 ± 0.4 μM, respectively. This study enriches the chemistry of the genus Guarea and further supports the identification of Meliaceae plants as a good source of antiplasmodial candidates for the development of new potent drugs against malaria.
- Open Access
- 17 August 2023
- Published by Elsevier in South African Journal of Botany
- Vol. 161, 269-280
Chemistry and biological activities of naturally occurring C-glycosylxanthones
- 17 August 2023
- Published by Elsevier in South African Journal of Botany
- Vol. 161, 269-280
Open AccessChemistry and biological activities of naturally occurring C-glycosylxanthones
- Open Access
- 1 January 2023
- Published by Wiley in BioMed Research International
- Vol. 2023 (1)
Bioassay‐Guided Isolation of Antiplasmodial Compounds from Hypericum lanceolatum Lam. (Hypericaceae) and Their Cytotoxicity and Molecular Docking
In Cameroon, malaria is still the cause of several deaths yearly and leading to the continued search for new potent leads to fight against Plasmodium falciparum. Medicinal plants like Hypericum lanceolatum Lam. are introduced in local preparations for the treatment of affected people. The bioassay‐guided fractionation of the crude extract of the twigs and stem bark of H. lanceolatum Lam. led to the identification of the dichloromethane‐soluble fraction as the most active (with 32.6% of the parasite P. falciparum 3D7 survival) which was further purified by successive column chromatography to obtain four compounds identified by their spectrometric data as two xanthones 1,6‐dihydroxyxanthone (1) and norathyriol (2) and two triterpenes betulinic acid (3) and ursolic acid (4). In the antiplasmodial assay against P. falciparum 3D7, the triterpenoids 3 and 4 displayed the most significant potencies with IC50 values of 2.8 ± 0.8 μg/mL and 11.8 ± 3.2 μg/mL, respectively. Furthermore, both compounds were also the most cytotoxic against P388 cell lines with IC50 values of 6.8 ± 2.2 μg/mL and 2.5 ± 0.6 μg/mL, respectively. Further insights on the inhibition method of the bioactive compounds and their drug‐likeness were obtained from their molecular docking and ADMET studies. The results obtained help in identifying additional antiplasmodial agents from H. lanceolatum and support its use in folk medicine for the treatment of malaria. The plant might be considered as a promising source of new antiplasmodial candidates in new drug discovery.
- 1 January 2023
- Published by Wiley in BioMed Research International
- Vol. 2023 (1)
Open AccessBioassay‐Guided Isolation of Antiplasmodial Compounds from Hypericum lanceolatum Lam. (Hypericaceae) and Their Cytotoxicity and Molecular Docking
In Cameroon, malaria is still the cause of several deaths yearly and leading to the continued search for new potent leads to fight against Plasmodium falciparum. Medicinal plants like Hypericum lanceolatum Lam. are introduced in local preparations for the treatment of affected people. The bioassay‐guided fractionation of the crude extract of the twigs and stem bark of H. lanceolatum Lam. led to the identification of the dichloromethane‐soluble fraction as the most active (with 32.6% of the parasite P. falciparum 3D7 survival) which was further purified by successive column chromatography to obtain four compounds identified by their spectrometric data as two xanthones 1,6‐dihydroxyxanthone (1) and norathyriol (2) and two triterpenes betulinic acid (3) and ursolic acid (4). In the antiplasmodial assay against P. falciparum 3D7, the triterpenoids 3 and 4 displayed the most significant potencies with IC50 values of 2.8 ± 0.8 μg/mL and 11.8 ± 3.2 μg/mL, respectively. Furthermore, both compounds were also the most cytotoxic against P388 cell lines with IC50 values of 6.8 ± 2.2 μg/mL and 2.5 ± 0.6 μg/mL, respectively. Further insights on the inhibition method of the bioactive compounds and their drug‐likeness were obtained from their molecular docking and ADMET studies. The results obtained help in identifying additional antiplasmodial agents from H. lanceolatum and support its use in folk medicine for the treatment of malaria. The plant might be considered as a promising source of new antiplasmodial candidates in new drug discovery.
- Open Access
- 26 October 2022
- Published by Hindawi Limited in Journal of Chemistry
- Vol. 2022, 1-21
Chemical Constituents from Uapaca guineensis (Phyllanthaceae), and the Computational Validation of Their Antileishmanial and Anti-inflammatory Potencies
From the chemical investigations of the root bark of Uapaca guineensis, nine distinct compounds (19) have been isolated and characterized as lupeol, betulin, betulinic acid, β-amyryl acetate, physcion, quercetin, rutin, β-sitosterol, and β-sitosterol-3-O-β-D-glucopyranoside, respectively. The structures of all the isolated compounds have been established using their NMR data as well as the comparison of those data with the ones reported in the literature. Interestingly, to the best of our knowledge, except for the lupane-type triterpenoids (13) and compounds 4 and 9, all the other compounds are reported for the first time from this genus. Since the plant is widely used for the treatment of skin diseases, leishmaniasis and inflammatory diseases, the antileishmanial and anti-inflammatory potencies of all the isolated compounds have been computationally validated through their ability to inhibit the receptors 1QCC and 2XOX (for the antileishmanial studies) and 6Y3C and 1CX2 (for the anti-inflammatory studies). Furthermore, the ADMET studies of compounds have been done to evaluate their drug-likeness. Results demonstrate that all the isolated compounds showed a better affinity for both receptors binding sites than the standard drugs miltefosine and aspirin. Moreover, the compounds would not cause addiction when used as lead molecules whereas, aspirin is predicted to violate the BBB over a long term of usage as a drug. This study gives additional information on the chemistry of U. guineensis and its classification as a potential source of good leads for the development of potent antileishmanial and anti-inflammatory drugs.
- 26 October 2022
- Published by Hindawi Limited in Journal of Chemistry
- Vol. 2022, 1-21
Open AccessChemical Constituents from Uapaca guineensis (Phyllanthaceae), and the Computational Validation of Their Antileishmanial and Anti-inflammatory Potencies
From the chemical investigations of the root bark of Uapaca guineensis, nine distinct compounds (19) have been isolated and characterized as lupeol, betulin, betulinic acid, β-amyryl acetate, physcion, quercetin, rutin, β-sitosterol, and β-sitosterol-3-O-β-D-glucopyranoside, respectively. The structures of all the isolated compounds have been established using their NMR data as well as the comparison of those data with the ones reported in the literature. Interestingly, to the best of our knowledge, except for the lupane-type triterpenoids (13) and compounds 4 and 9, all the other compounds are reported for the first time from this genus. Since the plant is widely used for the treatment of skin diseases, leishmaniasis and inflammatory diseases, the antileishmanial and anti-inflammatory potencies of all the isolated compounds have been computationally validated through their ability to inhibit the receptors 1QCC and 2XOX (for the antileishmanial studies) and 6Y3C and 1CX2 (for the anti-inflammatory studies). Furthermore, the ADMET studies of compounds have been done to evaluate their drug-likeness. Results demonstrate that all the isolated compounds showed a better affinity for both receptors binding sites than the standard drugs miltefosine and aspirin. Moreover, the compounds would not cause addiction when used as lead molecules whereas, aspirin is predicted to violate the BBB over a long term of usage as a drug. This study gives additional information on the chemistry of U. guineensis and its classification as a potential source of good leads for the development of potent antileishmanial and anti-inflammatory drugs.
- Open Access
- 25 August 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 3 (1) , 1-6
Chemistry and pharmacological aspects of Aridanin, a lead compound from Tetrapleura tetraptera (Fabaceae)
Aridanin, a triterpenoid N-acetylglycoside has been obtained from chemical investigations of the root of Tetrapleura tetraptera, a well-known seasoning spice from Cameroonian food. The structure of the compound has been established using its NMR data and by comparison of that data with the one reported in the literature. Further evidence has been compiled from literature and discussed on the occurrence, the extraction, isolation and analytical techniques as well as the reported biological activities of aridanin. Based on its potency and its high yield in Tetrapleura tetraptera fruits, the compound can be considered as lead compound in the development of medicine for the control of schistosomiasis and bacterial infections caused by the bacterial strainsE. coli, E. smartii and E. aeroginese. this paper sheds light on the compound aridanin which deserves more attention in the development of a new potent drug or on the formulation of Tetrapleura tetraptera for effective use by the local population.
- 25 August 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 3 (1) , 1-6
Open AccessChemistry and pharmacological aspects of Aridanin, a lead compound from Tetrapleura tetraptera (Fabaceae)
Aridanin, a triterpenoid N-acetylglycoside has been obtained from chemical investigations of the root of Tetrapleura tetraptera, a well-known seasoning spice from Cameroonian food. The structure of the compound has been established using its NMR data and by comparison of that data with the one reported in the literature. Further evidence has been compiled from literature and discussed on the occurrence, the extraction, isolation and analytical techniques as well as the reported biological activities of aridanin. Based on its potency and its high yield in Tetrapleura tetraptera fruits, the compound can be considered as lead compound in the development of medicine for the control of schistosomiasis and bacterial infections caused by the bacterial strainsE. coli, E. smartii and E. aeroginese. this paper sheds light on the compound aridanin which deserves more attention in the development of a new potent drug or on the formulation of Tetrapleura tetraptera for effective use by the local population.
- Open Access
- 16 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (2) , 129-141
Mushrooms (Basidiomycetes) as a significant source of biologically active compounds for malaria control
Mushrooms represent a large family of fleshy fungi that have been of high interest since ancient ages due to their medicinal and nutritional importance. Therefore, it can represent a significant source of bioactive compounds in malaria control. The few numbers of studies on in vitro antiplasmodial and insecticidal properties of their extracts and chemical constituents led to interesting results reported in numerous scientific publications. This review aims to provide a comprehensive compilation of literature up to 2021 on the antiplasmodial, insecticidal as well as cytotoxic chemical constituents of medicinal mushrooms that can help in the management of malaria both against the parasite Plasmodium falciparum and the mosquitoe Anopheles stephensis acting as a vector of malaria through its bites. For this purpose, some searches have been done in some online libraries using keywords like Basidiomycete, mushroom, malaria, Plasmodium, Anopheles and antiplasmodial without language restriction. Among the reported compounds, 51 selected ones displayed significant antiplasmodial potency with IC50 values lower than 10 μM against P. falciparum strains sensitive or resistant to chloroquine. For instance, ganoderic acid AW1 demonstrated a strong antiplasmodial activity with IC50 of 257.8 nM against P. falciparum D6, while strong activities were displayed by ganoweberianones A (IC50 = 0.050 μM) and B (IC50 = 0.46 μM) against P. falciparum K1. Moreover, some mushroom methanol extracts demonstrated good larvicidal and ovicidal activities against Anopheles stephensis. This paper provides further insights into the development of new antiplasmodial drugs or new potent eco-friendly pesticides to control mosquito vectors.
- 16 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (2) , 129-141
Open AccessMushrooms (Basidiomycetes) as a significant source of biologically active compounds for malaria control
Mushrooms represent a large family of fleshy fungi that have been of high interest since ancient ages due to their medicinal and nutritional importance. Therefore, it can represent a significant source of bioactive compounds in malaria control. The few numbers of studies on in vitro antiplasmodial and insecticidal properties of their extracts and chemical constituents led to interesting results reported in numerous scientific publications. This review aims to provide a comprehensive compilation of literature up to 2021 on the antiplasmodial, insecticidal as well as cytotoxic chemical constituents of medicinal mushrooms that can help in the management of malaria both against the parasite Plasmodium falciparum and the mosquitoe Anopheles stephensis acting as a vector of malaria through its bites. For this purpose, some searches have been done in some online libraries using keywords like Basidiomycete, mushroom, malaria, Plasmodium, Anopheles and antiplasmodial without language restriction. Among the reported compounds, 51 selected ones displayed significant antiplasmodial potency with IC50 values lower than 10 μM against P. falciparum strains sensitive or resistant to chloroquine. For instance, ganoderic acid AW1 demonstrated a strong antiplasmodial activity with IC50 of 257.8 nM against P. falciparum D6, while strong activities were displayed by ganoweberianones A (IC50 = 0.050 μM) and B (IC50 = 0.46 μM) against P. falciparum K1. Moreover, some mushroom methanol extracts demonstrated good larvicidal and ovicidal activities against Anopheles stephensis. This paper provides further insights into the development of new antiplasmodial drugs or new potent eco-friendly pesticides to control mosquito vectors.
- Open Access
- 13 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (3) , 322-326
Recent Advances on Pharmacology and Chemistry of Pycnanthus angolensis over the last decade (2012-2021)
Pycnanthus angolensis, widely known under its trade name "ilomba", is a medicinal plant from the family Myristicaceae that has occupied a prominent place in African traditional medicine for several decades; its broad application to treat numerous diseases, including malaria, bacterial infections and most recently COVID-19. The various chemical studies undertaken on the plant identified many classes of specialized compounds, including quinone-terpenoids, lignans and isoflavonoids, as the most abundant and bioactive components. The plant is defined as a major asset in developing new potent drugs and deserves further investigation in this regard. This mini-review aims to compile the newly documented findings on the traditional uses, phytochemistry and pharmacology of P. angolensis over the last decade from 2012 to 2021. In this regard, a literature search using the keyword Pycnanthus has been done without language restriction in numerous online libraries, including Scifinder, PubMed, Google Scholar, and only papers on Pycnanthus angolensis published after 2011 have been exploited during the writing.
- 13 January 2022
- Published by Visagaa Publishing House in Natural Resources for Human Health
- Vol. 2 (3) , 322-326
Open AccessRecent Advances on Pharmacology and Chemistry of Pycnanthus angolensis over the last decade (2012-2021)
Pycnanthus angolensis, widely known under its trade name "ilomba", is a medicinal plant from the family Myristicaceae that has occupied a prominent place in African traditional medicine for several decades; its broad application to treat numerous diseases, including malaria, bacterial infections and most recently COVID-19. The various chemical studies undertaken on the plant identified many classes of specialized compounds, including quinone-terpenoids, lignans and isoflavonoids, as the most abundant and bioactive components. The plant is defined as a major asset in developing new potent drugs and deserves further investigation in this regard. This mini-review aims to compile the newly documented findings on the traditional uses, phytochemistry and pharmacology of P. angolensis over the last decade from 2012 to 2021. In this regard, a literature search using the keyword Pycnanthus has been done without language restriction in numerous online libraries, including Scifinder, PubMed, Google Scholar, and only papers on Pycnanthus angolensis published after 2011 have been exploited during the writing.